Abstract 1979: Algebraic factorization of gene expression profiles reveals subtype-specific drug sensitivities among 54 breast cancer cell lines
William J. Gibb(Lawrence Berkeley National Laboratory), Joe W. Gray(University of Newcastle Australia), Heidi S. Feiler(Oregon Health & Science University), Jian‐Hua Mao(Cancer Research Institute), Eric A. Collisson(City College of San Francisco), James E. Korkola(Oregon Health & Science University), Paul T. Spellman(Oregon Health & Science University), Anguraj Sadanandam(Institute of Cancer Research), Lakshmi R. Jakkula(Lawrence Berkeley National Laboratory), Sophi Lewis(Lawrence Berkeley National Laboratory), Jessica I. Billig(Southwestern Medical Center), Safiyyah Ziyad(Bristol-Myers Squibb (United States)), Laura M. Heiser(Oregon Health & Science University), Marc E. Lenburg(Boston University), Zhi Hu(Oregon Health & Science University), Denise Wolf(Lawrence Berkeley National Laboratory), Wen‐Lin Kuo(Lawrence Berkeley National Laboratory), Nicholas Wang(Oregon Health & Science University), Nora Bayani(Lawrence Berkeley National Laboratory)
Cited by 0
Related Papers
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
|Cell|2020|602
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
|Journal of Clinical Investigation|2012|591
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
|Cancer Cell|2013|571
Subtype and pathway specific responses to anticancer compounds in breast cancer
|Proceedings of the National Academy of Sciences|2011|505